SOURCE: Wall Street News Alert

August 23, 2006 09:46 ET

HBSC Is Still on the Move: Forms Subsidiary for Ethanol Business! August 23, 2006

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

WESTON, FL -- (MARKET WIRE) -- August 23, 2006 -- Wall Street News Alert's "stocks to watch" this morning are: Human Biosystems (OTCBB: HBSC), Wyeth (NYSE: WYE), AVI BioPharma, Inc. (NASDAQ: AVII) and QUALCOMM Incorporated (NASDAQ: QCOM).

Once again, Human Biosystems (OTCBB: HBSC) is a company that aggressive investors and day traders are going to want to watch this morning! Yesterday after the stock markets closed, the company, a developer of preservation platforms for organs and other biomaterials, issued a press release announcing the formation of HBS BioEnergy ("HBE"), a wholly owned subsidiary of the company.

Recently the company had announced the signing of a letter of intent to enter the BioFuels business through the acquisition of two ethanol production facility projects from EXL III. In a press release, the company stated that it made the decision to enter the bio energy field because it gives HBS the potential to achieve substantial revenue and profit growth within a predictable timetable and that the acquisition should give HBS additional financing options not previously available.

News of the formation may be of interest to investors! This subsidiary is the first step toward establishing the organizational structure to consummate the acquisition and to carry out HBS's plan to build the facilities that will produce renewable fuel sources for the U.S. market.

HBS BioEnergy will operate as a separate company and subsidiary of HBS for the purpose of developing the bio energy business including the two ethanol fuel production facility projects to be acquired from EXL III Group Corporation ("EXL III") pursuant to the Letter of Intent ("LOI") mentioned in the press release dated July 27, 2006.

The commencement of any meaningful operation of HBE is dependent upon the signing of definitive agreements between HBS, EXL III and its principal Mr. Claude Luster III pursuant to the Letter of Intent signed in July 2006. The acquisition is expected to close in the fall of 2006, after certain conditions are met, including but not limited to completion of satisfactory due diligence by HBS, the negotiation and completion of a definitive acquisition agreement and Consulting Services Agreement, approval of the HBS and EXL III boards of directors and other customary conditions.

Wall Street News Alert is continuing to place Aggressive Investors on alert to monitor the progress of Human Biosystems! The company, whose primary business is the development of preservation platforms for organs and other biomaterials, is headquartered in Palo Alto, California with research facilities in Michigan, has been granted four patents by the U.S. Patent Office. HBS plans to market its preservation technologies worldwide, including a number of markets in the United States. Last week the company announced that it has signed an agreement with UTEK Corporation ("UTEK") to assist HBS in identifying and making introductions to potential business partners of the Company's preservation technology. According to Harry Masuda, CEO of Human BioSystems, "Partnering has been in our business plan from the beginning and it has been our goal to establish strategic partners who have the distribution channels required to sell our products worldwide."

Prior to the latest press release, the stock closed yesterday at Twenty cents a share. For an in-depth profile of Human Biosystems, visit

To view all of Wall Street News Alert's special early morning trading alerts for this morning, visit, where you may also sign up to receive free email alerts in advance of our press releases being issued.

Wyeth (NYSE: WYE) up 2.2% on 7.8 million shares traded. Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, cardiovascular disease, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

AVI BioPharma, Inc. (NASDAQ: AVII) up 19.5% on 4.6 million shares traded. AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs.

QUALCOMM Incorporated (NASDAQ: QCOM) up 1.1% on 14.4 million shares traded. QUALCOMM Incorporated is one of the leaders in developing and delivering innovative digital wireless communications products and services.

Market Commentary:

"Oil rumors abound Tuesday as news regarding Iran's announcement that they will consider the incentives given by the U.N. regarding uranium enrichment, helped to hold down oil prices. Oil dropped by 30 cents to $72.15 per barrel. Gold held at just over $630 an ounce," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at:

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 50 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at and select the "join now" button.

WSNA is a Platinum Sponsor of Quality Stocks. Quality Stocks tracks the stock picks of 150 Investment Newsletters every day and reports on their performance. For Their Free Service, Visit

*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its' Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has been compensated Eight Thousand Dollars for current coverage AND was previously compensated Sixty-Six Thousand Dollars for past coverage of Human Biosystems (OTCBB: HBSC), by the company, for services provided including dissemination of company information in this release. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Contact Information